iCo Therapeutics Inc.

(ICO:PUR)

By |

Profile

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with a clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. The business operations of the company are carried in Canada.

Contact Information

Website: www.icotherapeutics.com
Main Phone: +1 604 657-3882
Address: 777 Hornby Street
Address 2: 6th Floor
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6Z 1S4

Issuer Information

Exchange: CDX
CEO: Andrew Rae
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.055 $ -0.005 (-8.33%)
Last Price 0.055 Change $ -0.005 Change % -8.33 Tick N/A
Bid 0.055 Bid Size 41,000.00 Ask 0.06 Ask Size 11,000.00
Open 0.055 High 0.055 Low 0.055 Prev Close 0.06
Last Trade Volume 11,000 52 Wk Hi 0.27 52 Wk Low 0.03
Market Cap 4.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 84,457,713.00 EPS (TTM) -0.02 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.07 0.07 0.07 0.07
Low Target Price Estimate 0.07 0.07 0.07 0.07
Mean Target Price Estimate 0.07 0.07 0.07 0.07
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/02/15 03/02/15 03/02/15 03/02/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3